Azulfidine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Sulfasalazine.
| Product ID | 0013-0101_14feec56-0272-44f5-9315-6a496e19d251 | 
| NDC | 0013-0101 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Azulfidine | 
| Generic Name | Sulfasalazine | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 1950-06-20 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA007073 | 
| Labeler Name | Pfizer Laboratories Div Pfizer Inc | 
| Substance Name | SULFASALAZINE | 
| Active Ingredient Strength | 500 mg/1 | 
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 1950-06-20 | 
| Marketing End Date | 2024-08-31 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA007073 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1950-06-20 | 
| Marketing Category | NDA | 
| Application Number | NDA007073 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 1950-06-20 | 
| Marketing Category | NDA | 
| Application Number | NDA007073 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 1950-06-20 | 
| Marketing End Date | 2014-03-05 | 
| Marketing Category | NDA | 
| Application Number | NDA007073 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2020-02-27 | 
| Marketing Category | NDA | 
| Application Number | NDA007073 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2020-02-27 | 
| Ingredient | Strength | 
|---|---|
| SULFASALAZINE | 500 mg/1 | 
| SPL SET ID: | ddbe69f3-bd55-45f3-a64f-f60226c744c4 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0013-0101 | Azulfidine | Sulfasalazine | 
| 0013-0102 | Azulfidine | Sulfasalazine | 
| 0093-3234 | Sulfasalazine | Sulfasalazine | 
| 0591-0796 | Sulfasalazine | Sulfasalazine | 
| 0603-5801 | Sulfasalazine | sulfasalazine | 
| 10544-288 | Sulfasalazine | sulfasalazine | 
| 23155-019 | Sulfasalazine | Sulfasalazine | 
| 33261-756 | Sulfasalazine | sulfasalazine | 
| 43353-495 | Sulfasalazine | Sulfasalazine | 
| 50090-0086 | Sulfasalazine | Sulfasalazine | 
| 50090-2013 | Sulfasalazine | Sulfasalazine | 
| 50268-730 | Sulfasalazine | Sulfasalazine | 
| 59762-0104 | Sulfasalazine | Sulfasalazine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  AZULFIDINE  72071688  0689772 Live/Registered | PHARMACIA LABORATORIES, INC. 1959-04-16 |